Combined immunotherapy with two checkpoint inhibitors…
Archive | Clinical Trials
Combination immunotherapy shrinks melanoma brain metastases
Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial…
Posted in Melanoma News, Clinical Trials
Combination Approach Shows Promise For Beating Advanced Melanoma
Source: ScienMag, September 2018 A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer. The research showed that using the immunotherapy drug pembrolizumab and the experimental agent SD-101, a sequence of […]
Posted in Melanoma News, Clinical Trials
Adjuvant bevacizumab not recommended for melanoma, HER2-negative breast cancer
medwireNews: The AVAST-M and E5103 trial results rule out the use of bevacizumab in the adjuvant setting in high-risk patients with cutaneous melanoma and HER2-negative breast cancer, respectively.
Posted in Melanoma News, Clinical Trials
